Sector | Healthcare | Compare with Sector peers |
Industry | Hospital & Healthcare Services | Compare with Industry peers |
Website | http://www.scandent.in | |
Market Cap | 42.67 Cr. | |
Enterprise Value(EV) | 46.93 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 0.93 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | 8.49 | Trailing Twelve Months Ending 2023-12 |
Industry PE | 67.02 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 9.17 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 0.86 | Calculated using Price: 7.90 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 5.40 Cr. | 54,014,774 Shares |
FaceValue | 10 | |
About Family Care Hospitals Ltd. | ||
Scandent Imaging is pioneer in providing independent state of the art dental and ENT Imaging solutions. The company provides an exhaustive range of 3D and 2D scan services along with expert reports to cater to the requirements of the dental and ENT fraternity. They specialized and intend to provide complete scanning solutions to the growing demands of the dental and ENT fraternity. Scandent offers the best of technology and scanning experience. The company has designed unique imaging packages that match the requirements of the dental and ENT fraternity as well as the affordability of its end users. |
1 Day |
|
+1.54% |
1 Week |
|
+3.95% |
1 Month |
|
+3.95% |
3 Month |
|
-17.45% |
6 Month |
|
+6.33% |
1 Year |
|
-33.16% |
2 Year |
|
-62.63% |
5 Year |
|
-6.40% |
10 Year |
|
+375.90% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | -1394.79 | 0.51 | 3.92 | 18.96 | 0.38 | 0.57 | 57.85 | 44.6 | 17.51 | |
Return on Capital Employed (%) | -1096.64 | 0.58 | 4.85 | 25.41 | 7.15 | 7.03 | 44.54 | 45.74 | 23.2 | |
Return on Assets (%) | -1085.04 | 0.44 | 3.13 | 11.15 | 0.16 | 0.18 | 21.72 | 17.27 | 9.21 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 4 | 4 | 4 | 5 | 5 | 5 | 9 | 14 | 46 | 48 | |
Non Curr. Liab. | 0 | 0 | 0 | 6 | 7 | 6 | 6 | 8 | 9 | ||
Curr. Liab. | 1 | 1 | 1 | 5 | 3 | 5 | 5 | 20 | 21 | 19 | |
Minority Int. | |||||||||||
Equity & Liab. | 5 | 5 | 6 | 10 | 14 | 17 | 20 | 40 | 74 | 77 | |
Non Curr. Assets | 2 | 2 | 3 | 9 | 10 | 11 | 9 | 8 | 16 | 15 | |
Curr. Assets | 3 | 3 | 2 | 0 | 3 | 6 | 11 | 32 | 59 | 61 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 5 | 5 | 6 | 10 | 14 | 17 | 20 | 40 | 74 | 77 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 0 | 1 | 2 | 5 | 14 | 13 | 35 | 42 | 47 | 49 | |
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | |
Total Income | 0 | 1 | 2 | 5 | 14 | 13 | 35 | 42 | 48 | 51 | |
Total Expenditure | 0 | -1 | -2 | -4 | -13 | -11 | -27 | -33 | -39 | -41 | |
PBIDT | 0 | 0 | 0 | 2 | 2 | 2 | 8 | 9 | 9 | 9 | |
Interest | 0 | 0 | 0 | -1 | -1 | -1 | -1 | -1 | -1 | ||
Depreciation | 0 | 0 | 0 | 0 | -1 | -1 | -1 | -1 | -1 | -1 | |
Taxation | 0 | 0 | 0 | 0 | -2 | -2 | -2 | -2 | |||
Exceptional Items | -25 | ||||||||||
PAT | -25 | 0 | 0 | 1 | 0 | 0 | 4 | 5 | 5 | 5 | |
Adjusted EPS | -7 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | 0 | 0 | 0 | 3 | -3 | 0 | 4 | 2 | -5 | |
Cash Fr. Inv. | -2 | 0 | -1 | -5 | -2 | -2 | 0 | 0 | -2 | ||
Cash Fr. Finan. | 0 | 5 | 1 | 0 | 5 | 3 | -5 | -2 | 26 | ||
Net Change | 0 | 3 | 0 | 0 | -2 | 0 | 1 | -1 | 0 | 19 | |
Cash & Cash Eqvt | 0 | 3 | 3 | 2 | 0 | 0 | 2 | 0 | 0 | 19 |
Thu, 18 Apr 2024
Certificate Pursuant To Regulation 40 (9) Of SEBI (LODR) Regulations 2015 Certificate under Regulation 40 (9) of SEBI (LODR) Regulations 2015 for the year ended 31st March 2024 |
Wed, 17 Apr 2024
Intimation For Cancellation Of Board Meeting Scheduled To Be Held On April 17 2024 Board Meeting rescheduled to be held on April 17 2024 stands cancelled. |
Mon, 15 Apr 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the Quarter ended 31st March 2024 |
Fri, 26 Apr 2024 |
High Delivery Percentage |
Making Higher Highs for 3 days |
Making Higher Highs for 2 Days |
High Increase in 1 Month |
High Decrease in 3 Months |